Zhang Dai, Sun Jian-Ran, Xu Jiang, Xing Yan, Zheng Mao, Ye Shan-Dong, Zhu Jie
Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, Anhui Province, China.
Department of Endocrinology, Endocrinology Laboratory of the First Affiliated Hospital of USTC, Hefei 230001, Anhui Province, China.
World J Clin Cases. 2021 Mar 16;9(8):1923-1930. doi: 10.12998/wjcc.v9.i8.1923.
p.Tyr329fs is a cytochrome P450c17 mutation among Chinese individuals. However, data on 17-α-hydroxylase deficiency caused by cytochrome P450c17 p.Tyr329fs homozygous mutation are lacking. This paper is a case report of three patients homozygous for p.Tyr329fs who were diagnosed with 17-α-hydroxylase deficiency between 2005 and 2019.
Case 1 presented with hypertension, hypokalemia, sexual infantilism and delayed bone age. The patient had a 46, XY karyotype, was homozygous for p.Tyr329fs and was recently treated with dexamethasone 0.375 mg qn. Case 2 presented with hypokalemia, sexual infantilism, osteoporosis and delayed bone age. The patient had a 46, XY karyotype, was homozygous for p.Tyr329fs and was treated with dexamethasone 0.75 mg qn at the last follow-up. Serum potassium and blood pressure could be maintained within normal range for cases 1 and 2. Case 3 presented with amenorrhea, sexual infantilism, osteopenia and delayed bone age. The patient had a 46, XX karyotype, was homozygous for p.Tyr329fs and was treated with dexamethasone 0.75 mg qn and progynova 1 mg qd. Outpatient follow-up revealed an adrenocorticotropic hormone (8 AM) of < 5.00 pg/mL.
The homozygous p.Tyr329fs mutation usually manifests as a combined deficiency, and definitive diagnosis depends primarily on genetic testing.
p.Tyr329fs是中国人群中一种细胞色素P450c17突变。然而,关于细胞色素P450c17 p.Tyr329fs纯合突变导致17-α-羟化酶缺乏的数据尚缺。本文是3例p.Tyr329fs纯合子患者的病例报告,这些患者在2005年至2019年期间被诊断为17-α-羟化酶缺乏。
病例1表现为高血压、低钾血症、性幼稚症和骨龄延迟。患者核型为46,XY,为p.Tyr329fs纯合子,近期接受每晚0.375 mg地塞米松治疗。病例2表现为低钾血症、性幼稚症、骨质疏松症和骨龄延迟。患者核型为46,XY,为p.Tyr329fs纯合子,末次随访时接受每晚0.75 mg地塞米松治疗。病例1和病例2的血钾和血压可维持在正常范围内。病例3表现为闭经、性幼稚症、骨质减少和骨龄延迟。患者核型为46,XX,为p.Tyr329fs纯合子,接受每晚0.75 mg地塞米松和每日1 mg戊酸雌二醇治疗。门诊随访显示促肾上腺皮质激素(上午8点)<5.00 pg/mL。
p.Tyr329fs纯合突变通常表现为联合缺乏,明确诊断主要依赖基因检测。